Peripheral Neuropathy Trial, Recruiting (NCT07328360)

Peripheral Neuropathy Trial, Recruiting NCT07328360 Sponsor: Uşak University Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07328360 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 65 years of age.
People who have been diagnosed with meralgia paraesthetica (MP) — a nerve condition causing burning pain, tingling, or numbness in the outer thigh — based on their symptoms and a physical examination.
People whose symptoms have been present continuously for at least 3 months.
People whose pain is rated at least 4 out of 10 on a standard pain scale at the start of the trial.

Who may not be able to join:

People whose MP has been caused by a known underlying cause such as pelvic surgery, a physical injury, or a tumour shown on imaging.
People who have significant nerve pain coming from the lower spine (at the L1–L2 level).
People who have a blood clotting disorder or who are currently taking blood-thinning medications.
People who are pregnant.
People who have a skin condition or active skin infection in the area where treatment would be applied.
People who have a cardiac pacemaker.
People who have severe difficulties with memory, thinking, or understanding (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ali Y Karahan, Prof., University of Usak

Phone: +9053869219134

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07328360

Sponsor: Uşak University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +9053869219134

More information: https://clinicaltrials.gov/study/NCT07328360

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 65 years of age.
People who have been diagnosed with meralgia paraesthetica (MP) — a nerve condition causing burning pain, tingling, or numbness in the outer thigh — based on their symptoms and a physical examination.
People whose symptoms have been present continuously for at least 3 months.
People whose pain is rated at least 4 out of 10 on a standard pain scale at the start of the trial.

Who may not be able to join:

People whose MP has been caused by a known underlying cause such as pelvic surgery, a physical injury, or a tumour shown on imaging.
People who have significant nerve pain coming from the lower spine (at the L1–L2 level).
People who have a blood clotting disorder or who are currently taking blood-thinning medications.
People who are pregnant.
People who have a skin condition or active skin infection in the area where treatment would be applied.
People who have a cardiac pacemaker.
People who have severe difficulties with memory, thinking, or understanding (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Uşak University

Registry

ClinicalTrials.gov

Start date

12 January 2026

Est. completion

5 July 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

PainDETECT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov